Literature DB >> 20471858

Ischemia-modified albumin and heart fatty acid-binding protein: could early ischemic cardiac biomarkers be used in acute stroke management?

Fanny Herisson1, Odile Delaroche, Elisabeth Auffray-Calvier, Benjamin Daumas Duport, Benoit Guillon.   

Abstract

BACKGROUND: The detection of biomarkers such as ischemia-modified albumin (IMA) and heart fatty acid-binding protein (HFABP) is used in the early diagnosis of acute myocardial infarction. As these biomarkers are not organ specific, we tested them in the neurovascular field.
METHODS: A total of 41 patients with acute stroke were enrolled (31 ischemic strokes and 10 intracerebral hemorrhages). IMA and HFABP levels were measured in serum samples collected within 4.5 hours of stroke onset. Clinical, imaging, and outcome data were recorded.
RESULTS: No difference in baseline IMA or HFABP was found between patients with ischemic and hemorrhagic stroke. There was no correlation among biomarker levels at admission, National Institutes of Health Stroke Scale score, or stroke volume. Neither of the biomarkers could predict short-term prognosis.
CONCLUSIONS: IMA and HFABP do not appear to be relevant in acute stroke management. Copyright (c) 2010 National Stroke Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20471858     DOI: 10.1016/j.jstrokecerebrovasdis.2009.07.004

Source DB:  PubMed          Journal:  J Stroke Cerebrovasc Dis        ISSN: 1052-3057            Impact factor:   2.136


  2 in total

Review 1.  A Systematic Review and Meta-Analysis of Serum Concentrations of Ischaemia-Modified Albumin in Acute Ischaemic Stroke, Intracerebral Haemorrhage, and Subarachnoid Haemorrhage.

Authors:  Arduino A Mangoni; Angelo Zinellu
Journal:  Biomolecules       Date:  2022-04-29

2.  The prognostic significance of heart-type fatty acid binding protein in patients with stable coronary heart disease.

Authors:  Sing-Kong Ho; Yen-Wen Wu; Wei-Kung Tseng; Hsin-Bang Leu; Wei-Hsian Yin; Tsung-Hsien Lin; Kuan-Cheng Chang; Ji-Hung Wang; Hung-I Yeh; Chau-Chung Wu; Jaw-Wen Chen
Journal:  Sci Rep       Date:  2018-09-26       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.